Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹4,974Cr
Rev Gr TTM
Revenue Growth TTM
41.42%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TANFACIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 72.2 | 27.5 | 5.1 | -11.1 | -11.0 | -10.2 | 37.0 | 103.0 | 67.3 | 84.6 | 51.3 | -2.7 |
| 90 | 82 | 66 | 73 | 86 | 80 | 84 | 128 | 136 | 147 | 142 | 147 |
Operating Profit Operating ProfitCr |
| 22.4 | 22.7 | 19.2 | 16.6 | 15.9 | 16.4 | 24.4 | 28.2 | 20.8 | 16.5 | 15.9 | 14.9 |
Other Income Other IncomeCr | 6 | 3 | 2 | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 5 |
| 30 | 25 | 15 | 14 | 16 | 15 | 26 | 46 | 31 | 25 | 23 | 20 |
| 8 | 6 | 4 | 4 | 4 | 4 | 7 | 12 | 8 | 5 | 5 | 5 |
|
Growth YoY PAT Growth YoY% | 217.0 | 104.8 | 33.5 | -38.0 | -43.4 | -38.6 | 69.8 | 245.2 | 79.5 | 71.4 | -11.0 | -55.3 |
| 19.4 | 17.3 | 14.0 | 11.5 | 12.3 | 11.8 | 17.3 | 19.5 | 13.2 | 11.0 | 10.2 | 9.0 |
| 11.2 | 9.2 | 5.7 | 5.0 | 6.3 | 5.7 | 9.7 | 17.4 | 11.4 | 9.7 | 8.6 | 7.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 2.3 | 11.2 | -5.2 | 28.1 | 37.0 | -25.7 | -10.3 | 116.5 | 17.1 | 0.8 | 47.3 | 23.9 |
| 112 | 125 | 113 | 142 | 170 | 139 | 115 | 245 | 300 | 307 | 428 | 572 |
Operating Profit Operating ProfitCr |
| 6.3 | 6.2 | 11.0 | 12.6 | 23.4 | 15.7 | 22.1 | 23.5 | 19.9 | 18.7 | 23.1 | 17.0 |
Other Income Other IncomeCr | 0 | 4 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 7 | 3 | 3 |
Interest Expense Interest ExpenseCr | 9 | 7 | 7 | 6 | 3 | 1 | 1 | 1 | 1 | 1 | 3 | 5 |
Depreciation DepreciationCr | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 7 | 10 | 17 |
| -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 70 | 119 | 99 |
| -1 | 0 | 0 | 0 | 6 | 5 | 8 | 19 | 19 | 18 | 31 | 24 |
|
| -74.3 | 107.6 | 720.6 | 193.9 | 271.6 | -52.8 | 2.9 | 204.9 | 5.3 | -6.5 | 68.0 | -15.1 |
| -4.4 | 0.3 | 2.6 | 6.0 | 16.2 | 10.3 | 11.8 | 16.6 | 15.0 | 13.9 | 15.8 | 10.8 |
| -5.3 | 0.2 | 1.6 | 4.8 | 18.0 | 8.5 | 8.8 | 26.7 | 28.1 | 26.3 | 44.2 | 37.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| -10 | -10 | -7 | 3 | 38 | 55 | 73 | 124 | 174 | 220 | 302 | 330 |
Current Liabilities Current LiabilitiesCr | 89 | 85 | 67 | 66 | 48 | 19 | 33 | 45 | 63 | 66 | 108 | 115 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 1 | 7 | 7 | 12 | 5 | 4 | 4 | 4 | 5 | 7 | 7 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 40 | 40 | 30 | 42 | 70 | 48 | 75 | 128 | 189 | 201 | 246 | 237 |
Non Current Assets Non Current AssetsCr | 54 | 51 | 47 | 43 | 37 | 41 | 45 | 54 | 63 | 100 | 180 | 225 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 | 34 | 33 |
Investing Cash Flow Investing Cash FlowCr | 0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 | -30 | -42 |
Financing Cash Flow Financing Cash FlowCr | -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 | -7 | 32 |
|
Free Cash Flow Free Cash FlowCr | 9 | 15 | 15 | 17 | 35 | 11 | 29 | 29 | 28 | -2 | -64 |
| -174.1 | 3,998.4 | 483.2 | 179.6 | 102.6 | 128.5 | 212.9 | 82.5 | 76.5 | 65.2 | 37.3 |
CFO To EBITDA CFO To EBITDA% | 121.9 | 195.8 | 114.7 | 85.3 | 71.3 | 84.1 | 113.8 | 58.5 | 57.4 | 48.4 | 25.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 15 | 25 | 61 | 113 | 217 | 79 | 244 | 580 | 995 | 1,962 | 2,891 |
Price To Earnings Price To Earnings | 0.0 | 62.9 | 18.6 | 11.7 | 6.0 | 4.7 | 13.9 | 10.9 | 17.7 | 37.4 | 32.8 |
Price To Sales Price To Sales | 0.1 | 0.2 | 0.5 | 0.7 | 1.0 | 0.5 | 1.6 | 1.8 | 2.6 | 5.2 | 5.2 |
Price To Book Price To Book | -42.0 | 419.2 | 18.9 | 9.0 | 4.5 | 1.2 | 2.9 | 4.3 | 5.4 | 8.5 | 9.3 |
| 10.2 | 9.9 | 8.3 | 7.7 | 4.4 | 3.1 | 7.3 | 7.5 | 13.1 | 27.6 | 22.5 |
Profitability Ratios Profitability Ratios |
| 39.2 | 40.0 | 49.1 | 46.7 | 51.0 | 47.8 | 52.5 | 45.5 | 39.5 | 41.6 | 45.2 |
| 6.3 | 6.2 | 11.0 | 12.6 | 23.4 | 15.7 | 22.1 | 23.5 | 19.9 | 18.7 | 23.1 |
| -4.4 | 0.3 | 2.6 | 6.0 | 16.2 | 10.3 | 11.8 | 16.6 | 15.0 | 13.9 | 15.8 |
| 4.3 | 13.4 | 17.3 | 28.1 | 74.7 | 34.3 | 30.7 | 54.6 | 41.4 | 30.7 | 34.3 |
| 1,530.2 | 721.8 | 101.2 | 76.6 | 74.9 | 26.0 | 21.0 | 39.9 | 30.5 | 22.8 | 28.3 |
| -5.6 | 0.4 | 4.3 | 11.3 | 33.5 | 19.1 | 14.5 | 29.2 | 22.3 | 17.4 | 20.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Company Overview**
Tanfac Industries Limited, formerly known as Tamil Nadu Fluorine and Allied Chemicals Limited (incorporated in 1972), is a leading Indian chemical manufacturer specializing in fluorine-based chemicals. Established in 1985, the company operates a 60-acre integrated manufacturing facility at the SIPCOT Industrial Estate in Cuddalore, Tamil Nadu—strategically located approximately 180–200 km from Chennai.
Tanfac is a joint-sector enterprise promoted by **Anupam Rasayan India Limited** and the **Tamil Nadu Industrial Development Corporation (TIDCO)**. Since Anupam Rasayan acquired a significant stake in May 2022, the company has undergone a strategic transformation, shifting from commodity chemicals toward **specialty and high-value fluorinated products**, enhancing technical expertise, R&D capabilities, and market diversification.
---
### **Core Business Segments & Product Portfolio**
Tanfac operates in two primary revenue segments:
1. **Hydrofluoric Acid (HF) and Derivatives** (70% of revenue):
- Serves refrigerant gas, surface treatment, advanced intermediates, and solar cells.
- Key products: Anhydrous Hydrofluoric Acid (AHF), Dilute Hydrofluoric Acid (DHF), and fluorocarbon feedstocks.
2. **SAP and HF-Based Chemicals**:
- Supplies agrochemicals, pharmaceutical intermediates, specialty gases, glass etching, and metallurgical applications.
**Major Products Include:**
- Anhydrous & Dilute Hydrofluoric Acid (DHF)
- Aluminum Fluoride
- Potassium Fluoride & Potassium Bifluoride
- Boron Trifluoride Complexes
- Sulfuric Acid, Oleum, Calcium Sulphate (Gypsum)
- Iso Butyl Acetophenone
---
### **Strategic Expansion & Recent Milestones (2023–2025)**
1. **HF Production Capacity Doubled (2024):**
- Commissioned a new 52 TPD hydrofluoric acid plant in October 2024, increasing AHF capacity from 14,850 TPA to **29,700 TPA**.
- Investment: ₹100 crore (fully funded via internal accruals).
- Outcome: Enhanced in-house HF supply for downstream value-added products, improved cost efficiency, and stronger vertical integration.
2. **India’s First Solar-Grade Dilute HF Facility (2025):**
- Commissioned a **10,000 TPA Solar-Grade DHF (50% HF)** plant in June 2025—first of its kind in India.
- Certified by a leading Indian solar wafer manufacturer, validating product purity.
- **Phase II underway**, doubling capacity to **20,000 TPA** by FY26, supporting India’s renewable energy and solar manufacturing growth.
3. **Entry into Refrigerant Gases (2025):**
- Signed a long-term supply agreement with a U.S.-Japan-India consortium to manufacture refrigerant gases.
- **Annual revenue potential: ₹750 crore (~USD 86 million)**.
- Investment: ₹370 crore (via internal accruals and equity).
- Initial supply expected in **H2 FY27** from the Cuddalore facility with upgraded infrastructure.
- Strategic move to diversify into high-growth, regulated specialty markets.
4. **Downstream & Specialty Chemical Growth:**
- Focus on **high-value fluorine derivatives** for electronics, pharmaceuticals, renewables, and agrochemicals.
- Investing in R&D for **organic synthesis, custom fluorinated molecules, and fluoropolymers**.
- Planned commissioning of **new specialty inorganic fluoride plants in FY26**, using in-house technology.
---
### **R&D and Innovation**
- Active R&D center with **over 10 scientists** driving innovation in both organic and inorganic fluorine chemistry.
- Focus areas:
- Development of new fluorinated intermediates for pharma and electronics.
- Process optimization and energy efficiency (e.g., **low-cost steam-driven fluorspar dryer** installed).
- Custom molecule design for niche customer needs.
- Collaborating with global technology providers to access cutting-edge fluorine specialties and polymers.
---
### **Operations & Sustainability**
- **Advanced Technology:** Uses licensed tech from BUSS Chemtech (Switzerland) and CHENCO (Germany) for high-purity HF production.
- **Hazardous Material Expertise:** Specialized infrastructure for safe storage, handling, and logistics of hazardous chemicals—ensuring compliance, reliability, and safety.
- **Sustainability Initiatives:**
- Strong focus on **energy and water conservation**, **waste reduction**, and **carbon footprint management**.
- Recognized as a **Responsible Care signatory**, reflecting commitment to environmental, health, safety, and ethical standards.
- **Workforce & Productivity:**
- Increased training hours and incentive programs have improved employee productivity and reduced attrition.
- Manpower rationalized over time to enhance efficiency.
---
### **Market & Customer Reach**
- **Global Footprint:** Supplies **20 international clients across 10–12 countries**.
- Customer base spans pharmaceuticals, agrochemicals, solar, electronics, glass, and metallurgy sectors.
- **Export Strategy:**
- Facing short-term decline in export turnover (₹17.8 crore in FY24, down 4%) due to strong domestic demand.
- **Future focus: Expand exports** in Asia-Pacific and new global markets, especially for specialty-grade HF and VAPs.
---
### **Raw Material & Risk Mitigation**
- **Fluorspar & Potassium Carbonate:** Diversified sourcing away from China to reduce supply chain risk and dollar volatility.
- **Sulfur Supply:** Secured long-term supply agreement with a refinery for molten sulfur, ensuring cost stability.
- **Procurement Efficiency:** Negotiated pricing below international benchmarks for key raw materials.